University of California, San Francisco

University of California, San Francisco

Signal active

Investment Firm

Overview

UCSF scientist over twenty-five (25) years, twenty-three as Director of the Laboratory for Cell Analysis (LCA). Currently Director of the Lab for Advanced Cytometry (LAC) and the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine.

• Built the LCA into one of the largest academic cytometry core facilities worldwide. • Direct contribution to grants totals well over $40M in extramural funding. • Helped design and build five commercial flow cytometers, two cell sorters, and two commercial confocal microscopes.

Current work supports several developing technology fields including automated digital pathology and laser-based microdissection systems, next generation clinical cell sorters, spectral flow cytometry, chip-based cytometry and point-of-care devices, wide-field high-resolution deep tissue confocal microscopy, mass spec flow cytometry (CyTOF), and spectral in vivo imaging. Application development includes single cell genomics, new functional reporter probes for cell cycle, cellular biosensors, FRET/FRAP/FLIM reporters for monitoring protein and drug interactions, new encoded carrier technology for immune profiling and liquid arrays, and rapid identification systems for virology and microbiology. Hyun also participates in biomedical software and database design, and testing of new algorithms for cytometric data processing and presentation of results.

Highlights

Founded

1873

Industry

Biotechnology

Employees

10001+

Investment

2

Lead Investment

0

Exits

undefined

Stages

Early Stage Venture, Late Stage Venture

Investor Type

N/A

Location

United States, North America

Contact Information

Social

Profile Resume

University of California, San Francisco, established in 1873 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture investments across Cloud Computing, Biotechnology, Life Science, Medical, Information Technology, Energy, Health Care, Industrial Automation, Social, Non Profit. Their recent investments include ArsenalBio, Hitachi Ventures, Emerson Collective, Kleiner Perkins, Bristol-Myers Squibb. The highest investment round they participated in was $33.1B. Among their most notable exits are ArsenalBio and Hitachi Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Arthur Kern

Arthur Kern

Member of the Board of Directors, University of California at San Francisco Foundation

imagePlace Stephen Conn

Stephen Conn

Resident Physician

imagePlace Atul Butte

Atul Butte

Priscilla Chan and Mark Zuckerberg Distinguished Professor and Institute Director

imagePlace Aenor Sawyer

Aenor Sawyer

Director, University of California, Space Health; Dir. Skeletal Health Service

imagePlace Nancy Byl

Nancy Byl

Professor and Chair Emeritus

imagePlace Michael Kavanaugh

Michael Kavanaugh

Associate Clinical Professor of Medicine

Investment portfolio

University of California, San Francisco has made 2 investments. Their most recent investment was on Sep 06, 2022, when ArsenalBio raised $220.8M.

investments

2

Diversity investments

1

Lead investments

0

Number of exits

undefined

Investments

2

Annouced DateOrganization NameIndustryMoney Raised
Sep 01, 2020--33.5M
Sep 06, 2022
ArsenalBio ArsenalBio
Cloud Computing220.8M

Exits

0

Funding Timeline

Funding rounds

2

Investors

9

Funds

0

Funding Rounds

2

University of California, San Francisco has raised 2 rounds. Their latest funding was raised on Sep 06, 2022 from a Series B - ArsenalBio round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Sep 01, 2020
Series C - Hazel Health Series C - Hazel Health
-33.5M-
Sep 06, 2022
Series B - ArsenalBio Series B - ArsenalBio
-220.8M-

Investors

9

University of California, San Francisco is funded by 9 investor(s). Baldrick's Foundation and American Medical Association Kantor are the most recent investors.

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.